'For the quarter ending Sept 2023, consolidated Net sales (including other operating income) of Dr Lal Pathlabs has increased 12.65% to Rs 601.3 crore compared to quarter ended Sept 2022. Operating profit margin has jumped from 26.94% to 29.57%, leading to 23.64% rise in operating profit to Rs 177.80 crore.  Raw material cost as a % of total sales (net of stock adjustments) decreased from 21.77% to 20.36%.   Employee cost increased from 17.03% to 17.53%.   Other expenses fell from 34.26% to 32.55%.   Selling and administration expenses rose from 13.92% to 14.17%.   

Other income rose 108.05% to Rs 18.1 crore.  PBIDT rose 28.46% to Rs 195.9 crore.  Provision for interest fell 28.44% to Rs 7.8 crore.  Loan funds rose to Rs 299.20 crore as of 30 September 2023 from Rs 285.40 crore as of 30 September 2022.  Inventories declined from Rs 54.50 crore as of 30 September 2022 to Rs...

• 

  (12-Jul-2025)

  Elecon Engineering Company

  Net up 139% inflated by higher one off income
• 

  (12-Jul-2025)

  Avenue Supermarts

  Revenue up 16.3% YoY to Rs 16359.7 crore, Net profit flat at Rs 773 crore in Q1FY2026
• 

  (11-Jul-2025)

  Tata Consultancy Services

  Revenue up 1.3% YoY to Rs 63437 crore in Q1FY2026
• 

  (11-Jul-2025)

  Tata Elxsi

  Revenue down 3.7% YoY to Rs 892.1 crore in Q1FY2026